Gene · 28874
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Data Quality in Electronic Health Record Research: An Approach for Validation and Quantitative Bias Analysis for Imperfectly Ascertained Health Outcomes Via Diagnostic Codes. | Harv Data Sci Rev | 2022 | 36324333 | PubTator, text mining | PubMed |
| DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen. | Cell Death Discov | 2022 | 36316326 | PubTator, text mining | PubMed |
| Ginsengenin derivatives synthesized from 20(R)-panaxotriol: Synthesis, characterization, and antitumor activity targeting HIF-1 pathway. | J Ginseng Res | 2022 | 36312731 | PubTator, text mining | PubMed |
| Barriers to the Cervical Cancer Screening by CPC-28 Questionnaire: A Pilot Study. | Arch Clin Biomed Res | 2022 | 36311161 | PubTator, text mining | PubMed |
| Pathobiological functions and clinical implications of annexin dysregulation in human cancers. | Front Cell Dev Biol | 2022 | 36247003 | PubTator, text mining | PubMed |
| KIR-HLA gene diversities and susceptibility to lung cancer. | Sci Rep | 2022 | 36241658 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
| Anticancer Therapeutic Strategies Targeting p53 Aggregation. | Int J Mol Sci | 2022 | 36232329 | PubTator, text mining | PubMed |
| Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice. | J Biomed Sci | 2022 | 36224625 | PubTator, text mining | PubMed |
| Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolism. | Sci Rep | 2022 | 36220979 | PubTator, text mining | PubMed |
| Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2. | iScience | 2022 | 36213007 | PubTator, text mining | PubMed |
| Editorial: Molecules of the extracellular matrix as cancer targets. | Front Oncol | 2022 | 36203416 | PubTator, text mining | PubMed |
| Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. | NPJ Parkinsons Dis | 2022 | 36202848 | PubTator, text mining | PubMed |
| Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents. | J Enzyme Inhib Med Chem | 2022 | 36189734 | PubTator, text mining | PubMed |
| Can Second Coordination Sphere and Long-Range Interactions Modulate Hydrogen Atom Transfer in a Non-Heme Fe(II)-Dependent Histone Demethylase? | JACS Au | 2022 | 36186565 | PubTator, text mining | PubMed |
| Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy. | J Immunother Cancer | 2022 | 36180070 | PubTator, text mining | PubMed |
| SAR study of oxidative DIMs analogs targeting the Nur77-mediated apoptotic pathway of cancer cells. | Bioorg Chem | 2022 | 36179441 | PubTator, text mining | PubMed |
| A preclinical model of cutaneous melanoma based on reconstructed human epidermis. | Sci Rep | 2022 | 36175453 | PubTator, text mining | PubMed |
| Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890. | J Biol Chem | 2022 | 36174676 | PubTator, text mining | PubMed |
| p53 amyloid aggregation in cancer: function, mechanism, and therapy. | Exp Hematol Oncol | 2022 | 36171607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28874/papers?page=13